发明公开
- 专利标题： NOVEL OXOISOQUINOLINE DERIVATIVE
-
申请号： EP17874560.0申请日： 2017-11-24
-
公开(公告)号： EP3546462A1公开(公告)日： 2019-10-02
- 发明人: KAWAHATA, Wataru , KIYOI, Takao , IRIE, Takayuki , ASAMI, Tokiko , SAWA, Masaaki , KASHIMOTO, Shigeki
- 申请人： Carna Biosciences, Inc.
- 申请人地址： 1-5-5, Minatojima-Minamimachi Chuo-ku Kobe-shi, Hyogo 650-0047 JP
- 专利权人： Carna Biosciences, Inc.
- 当前专利权人： Carna Biosciences, Inc.
- 当前专利权人地址： 1-5-5, Minatojima-Minamimachi Chuo-ku Kobe-shi, Hyogo 650-0047 JP
- 代理机构： Kador & Partner PartG mbB
- 优先权： JP2016229262 20161125; JP2017191488 20170929
- 国际公布： WO2018097234 20180531
- 主分类号： C07D487/04
- IPC分类号： C07D487/04 ; A61K31/519 ; A61P19/00 ; A61P29/00 ; A61P35/00 ; A61P37/06 ; A61P43/00
摘要：
The present invention provides with an oxoisoquinoline derivative represented by the formula (I) (in the formula, Q and R 1 are as defined in the description) or a pharmaceutically acceptable salt thereof, which is useful as a Bruton's kinase inhibitor for treating cancer, B-cell lymphoma, chronic lymphocytic leukemia and the like.
公开/授权文献
- EP3546462B1 NOVEL OXOISOQUINOLINE DERIVATIVE 公开/授权日：2024-01-03
信息查询
